Efficacy of intravenous NEPA, a fixed NK1/5-HT3 receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin- and anthracycline cyclophosphamide (AC)-based chemotherapy: A review of phase 3 studies

Autor: Aapro, Matti *, Navari, Rudolph M., Roeland, Eric, Zhang, Li, Schwartzberg, Lee
Zdroj: In Critical Reviews in Oncology / Hematology January 2021 157
Databáze: ScienceDirect
Externí odkaz: